Sen. Ron Wyden hopes his new plan could jump-start drug pricing talks, which have stalled over concerns from moderate Democrats.
Related posts:
Half of U.S. adults now have received at least 1 Covid shot
FDA readies plan to bar menthol cigarettes nationwide
CDC director: Mask-wearing will ‘be hard to let go’ despite new guidance
Supreme Court pulls Biden into an abortion fight he didn’t want
Where Biden’s vaccine mandate will hit and miss
A global fight looms over Kratom, a possible opioid alternative
Diet-related diseases pose a major risk for Covid-19. But the U.S. overlooks them.
Surgeon general defends embattled vaccine mandate
U.S. J&J Covid vaccine doses will be sent to Thailand-Myanmar border
So long, Omicron: White House eyes next phase of pandemic
Medicare beneficiaries to get no-cost at-home Covid-19 tests
Lander backs out of congressional hearing amid bullying allegations
